Our data confirmed that older age, positivity for anti-SSB and anti-Ro52 antibodies, and changes in the levels of circulating immune cells, such as NK, Treg, and Th2 cells, are involved in the development of ILD in patients with pSS. This evidence concerns the gene TRIM21 and peeling skin syndrome.